Liquid Biopsy Market Followed by North America is expected to account for the largest share of the global liquid biopsy market in 2017, while Asia Pacific is expected to witness the highest growth during 2017 to 2022.
- Agency -.
Liquid Biopsy Market Research is Provides The global Liquid Biopsy Market size to reach USD 2,047.9 million by 2022 And is estimated to grow at a CAGR of 23.4% from 2017 to 2022,
The Professional Global Liquid Biopsy Market Research
“The non-cancer application segment is projected to grow at the highest CAGR during the forecast period”
Based on application, the liquid biopsy market is segmented into cancer and non-cancer applications (which include reproductive health and organ transplant diagnostics). The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.
This is due to the growing application in noninvasive prenatal testing (NIPT), using cell-free DNA assays in the identification of trisomies (which includes 13, 16, and 18), gender identification, and other genetic abnormalities such as monosomy X and microdeletions. NIPT is also rapidly replacing amniocentesis in high-risk pregnancies, thus expanding its application.
- Agency -.
“Extracellular vesicles to register the highest CAGR during the forecast period”
Based on circulating biomarkers the market is categorized into circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs) and other circulating biomarkers. The extracellular vesicles segment is the fastest-growing segment in the circulating biomarkers market during the forecast period.
- Liquid biopsy system manufacturers, suppliers, and distributors
- Research institutes
- Physicians and surgeons
- Healthcare service providers and clinical research organizations
- Market research and consulting firms
*Top 13+ Companies Analyzed for This Studies are- Some of the major market players in the liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US),Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDxHealth SA (US).
Access Liquid Biopsy Market 2017-2021 Spreads Across 204 Pages Profiling 13+ Companies and Supported with 133 Tables And 44 Figures Available at www.rnrmarketresearch.com/contacts…unt?rname=640498
Key Point from Table of Content
Liquid Biopsy Market, By Product and Service
Liquid Biopsy Market, By Circulating Biomarker
Circulating Tumor Cells
Circulating Tumor DNA (CTDNA)
Liquid Biopsy Market, By Clinical Application
Early Cancer Screening
Liquid Biopsy Market, By Application
Access this Report @ www.rnrmarketresearch.com/contacts…ase?rname=640498
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: